Anticonvulsant activity of a nonpeptide galanin receptor agonist.Peripheral blood RNA expression profiling in illicit methcathinone users reveals effect on immune systemDesign, synthesis and properties of novel powerful antioxidants, glutathione analogues.Characterization of UPF peptides, members of the glutathione analogues library, on the basis of their effects on oxidative stress-related enzymes.Cigarette smoke-induced differential regulation of glutathione metabolism in bronchial epithelial cells is balanced by an antioxidant tetrapeptide UPF1.Increased DNA damage in progression of COPD: a response by poly(ADP-ribose) polymerase-1.E-Cigarette Affects the Metabolome of Primary Normal Human Bronchial Epithelial Cells.Mutations in the SLAC1 anion channel slow stomatal opening and severely reduce K+ uptake channel activity via enhanced cytosolic [Ca2+] and increased Ca2+ sensitivity of K+ uptake channels.Peripheral blood RNA gene expression profiling in patients with bacterial meningitis.Hypothalamic gene expression profile indicates a reduction in G protein signaling in the Wfs1 mutant mice.Targeting of antisense PNA oligomers to human galanin receptor type 1 mRNA.The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease.Alterations of bronchial epithelial metabolome by cigarette smoke are reversible by an antioxidant, O-methyl-L-tyrosinyl-γ-L-glutamyl-L-cysteinylglycine.Silencing of the WFS1 gene in HEK cells induces pathways related to neurodegeneration and mitochondrial damage.Novel mastoparan analogs induce differential secretion from mast cells.Diverse Effects of Glutathione and UPF Peptides on Antioxidant Defense System in Human Erythroleukemia Cells K562.Oxidative stress and information content of black and yellow plumage coloration: an experiment with greenfinches.Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling.Amyloid precursor protein carboxy-terminal fragments modulate G-proteins and adenylate cyclase activity in Alzheimer's disease brain.Mechanism and stoichiometry of 2,2-diphenyl-1-picrylhydrazyl radical scavenging by glutathione and its novel alpha-glutamyl derivative.Oxidative stress due to (R)-styrene oxide exposure and the role of antioxidants in non-Swiss albino (NSA) mice.Crude glycerol as glycogenic precursor in feed; effects on milk coagulation properties and metabolic profiles of dairy cows.Manual solid-phase synthesis of glutathione analogs: a laboratory-based short course.Blood serum metabolome of atopic dermatitis: Altered energy cycle and the markers of systemic inflammation.Metabolomics of the Wolfram Syndrome 1 Gene (Wfs1) Deficient Mice.Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment.Glutathione system in Wolfram syndrome 1‑deficient mice.Metabolomic signature of arterial stiffness in male patients with peripheral arterial disease.Gene expression analysis of melanocortin system in vitiligo.Phenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical Characteristics.Prediction of Cell-Penetrating Peptides
P50
Q24531395-F2EBD232-9A4F-41EF-8149-465FEF0DB02EQ28396147-8455FE0B-C2A7-4FA7-8F4D-D44482D956E8Q33288138-706BA1D6-5CAA-42AA-AB2C-40FF44A4D5FFQ33441472-CB53E157-A61B-4058-8C89-FF4C459BFC62Q34444645-3036A68E-0D66-426F-AF76-289CA7E2A2B3Q34876209-83B21AD7-D0BB-4E7E-B28D-448EC3397CB1Q35831989-6ED72FF2-16AC-4D0B-B547-6746B1DE038BQ36428909-A4FD0D04-E97A-4590-BA21-5108B339AEA9Q36693885-9C058FF0-244D-44F0-9465-4BC1E5C3AD9CQ38330827-E736C4E5-90BF-484C-B019-0638370BE432Q38335854-26A75AF5-2CC9-4A94-87E0-3A853C77D76EQ38684901-BF63822C-3114-4573-BC72-917D7F110AC1Q38997083-39DF0CE2-E8C0-4F7A-9D9F-4F5B35F754EEQ39210046-F7D6BBCF-A71A-4014-8546-F3E09A51BE31Q40751249-A99850DC-3497-447F-91B8-012F886104C8Q41974927-FE4E3903-2D96-4BAA-A5CB-919CA27D1187Q43027426-FC7E92DD-D2B9-41E5-9AC2-105427A2946AQ43267875-A941EB2F-57F3-4A78-98B4-C08F585A2E16Q44590019-3C32E9A1-C620-4392-9FA3-7F247FFD113DQ45987416-EE902A1F-2D5D-4B3B-AD7D-B00D049D097FQ46077655-22CB5375-E0F4-4F71-B9B0-07E4FA380F56Q46501786-6E6D3A9F-C1C1-46BB-94E0-A4DC65E50319Q46619373-8A00DD79-CE36-4FE3-AEE8-E09BCF21DA43Q47159890-EE836E85-8589-4E72-B161-05F83F80BE36Q47275319-264C799F-968F-48E5-B536-D11BFEEB2CB1Q48275162-4BC198DE-A26E-49DE-9507-1CD1B53CB5D1Q50122437-E47B685B-AB7E-48DA-8ABA-ADCC6C2461D4Q53193084-734469A5-AA81-4F8E-BD9B-CF39564C135BQ55044231-561F5AD1-23E0-458C-8F50-BFB09BC562ACQ55232881-9DC582AA-11A6-4419-AA8A-0C7AA0A6B140Q59662714-5096A2C6-8D22-4207-9F76-ADC00BFBE33D
P50
description
eesti biokeemik
@et
onderzoeker
@nl
name
Ursel Soomets
@et
type
label
Ursel Soomets
@et
prefLabel
Ursel Soomets
@et
P106
P21
P214
8068149544622000490007
P2953
Ursel_Soomets
P31
P569
1962-07-18T00:00:00Z
P7859
viaf-8068149544622000490007